Document is current
Any future updates will be listed below
-
Authors
Mimpen, Jolet Y. https://orcid.org/0000-0003-4464-242X
Hedley, Robert
Ridley, Anna
Baldwin, Mathew J.
Windell, Dylan
Bhalla, Ananya
Ramos-Mucci, Lorenzo
Buckley, Christopher D.
Coles, Mark C.
Alvand, Abtin
Price, Andrew J.
Carr, Andrew J.
Dakin, Stephanie G.
Snelling, Sarah J. B.
-
Funding
Funding for this research was provided by:
NIHR Oxford Biomedical Research Centre
Chan Zuckerberg Initiative
Dunhill Medical Trust
Royal College of Surgeons of England
Lord Nuffield Trust
Medical Research Council (MR/S025308/1, MR/S025308/1)
Wellcome Trust
Versus Arthritis (22425)
- License Information
-
More Information
Article History
Received: 20 October 2022
Accepted: 10 July 2023
First Online: 23 August 2023
Declarations
:
: Ethical approval for the Oxford Musculoskeletal Biobank (09/H0606/11 and 19/SC/0134) was granted by the Oxford Research Ethics Committee B for all work on human synovium, and written informed consent according to the Declaration of Helsinki was obtained from all patients.
: Not applicable
: Christopher D. Buckley and Mark C. Coles are co-founders, shareholders, and scientific advisory board members of Mestag Therapeutics, and Mark Coles is a co-founder, shareholder, and director at Lightox Therapeutics.
